Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

Swiss Clinical Trial Organisation

  1. Events
  2. Organisers
  3. Swiss Clinical Trial Organisation
Events from this organiser
Today

Basel

SCTO Symposium 2025

A significant disconnect persists between the knowledge produced by randomized controlled trials (RCTs) and its consistent implementation in clinical practice. Addressing this gap necessitates targeted [...]

Contractors

Timesheet Portal

Clients
Legal
Contact Us

Copyright © 2025 | Hlx Life Sciences

Site by theLEAP

Go to Top